Creative Planning Iveric Bio, Inc. Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	BUY	$26.24 - $39.63 $153,713 - $232,152	5,858 New	5,858 $230,000
Q2 2022 Aug 15, 2022	BUY	$9.12 - $18.9 $1,459 - $3,024	160 Added 0.56%	28,790 $277,000
Q3 2021 Nov 10, 2021	SELL	$7.07 - $17.5 $181,310 - $448,787	-25,645 Reduced 47.25%	28,630 $465,000
Q2 2021 Aug 04, 2021	SELL	$5.69 - $7.17 $3,675 - $4,631	-646 Reduced 1.18%	54,275 $342,000
Q2 2019 Jul 26, 2019	BUY	$1.21 - $1.48 $66,454 - $81,283	54,921 New	54,921 $71,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.